Pathology is Phenotyping. What Do Pathologists Do? How Do they Do It?
Dean Troyer, Provia Biologics, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
Martin Gijs, Ecole Polytechnique Federale de Lausanne, speaking at Lab-on-a-Chip European Congress 2014.
TagLite® 2 cell assay - the next dimension to discovering new antibody drugs
Sandra Grau-Richards, Senior Scientist/Team Leader Roche-Glycart
Monitoring Dynamic Interactions of Tumor Cells with Tissue and Immune Cells in a Lab-on-a-Chip
Peter Ertl, Austrian Institute of Technology, speaking at Lab-on-a-Chip European Congress 2014.
Detection and Expression Profiling of Tumor Initiating Cells (TIC) Among the Peripherally Circulating Epithelial Tumor Cells from Patients with Breast Cancer
Katharina Pachmann, University of Jena, speaking at Single Cell Analysis Europe 2014.
Improvements in Molecular Diagnosis of Pathogens and Diseases
Panagiotis Karanis, University of Cologne, speaking at Advnaces in Biodetection & Biosensors 2014.
Challenges of Implementing and Validating CTC Assays in Oncology Clinical Trials
Iman Jilani, Pfizer, speaking at Exosomes and Circulating Biomarkers Summit 2013.
NanoVelcro-Embedded MicroChips for Detection and Isolation of Circulating Tumor Cells
Professor Hsian-Rong Tseng, UCLA, speaking at Exosomes and Circulating Biomarkers Summit 2013.
Alternative mRNA Cleavage and Polyadenylation in Genetic Diseases
Reuven Agami, The Netherlands Cancer Institute, speaking at Genomics Research Europe 2013.